Your session is about to expire
← Back to Search
PXL-330 Platinum device for crosslinking with Peschke riboflavin solution for Keratoconus
Study Summary
This trial will test a new machine that uses a different method to do cross-linking, to see if it is effective and safe.
- Pellucid Marginal Corneal Degeneration
- Keratoconus
- Corneal Ectasia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the upper limit for enrolment in this research?
"Affirmative. The details hosted on clinicaltrials.gov verify that this clinical trial is actively seeking participants, and it was initially posted on June 1st 2020 before being updated lastly on January 24th 2022. This study requires 300 individuals to be recruited from two distinct locations."
Has research been conducted on the efficacy of using a PXL-330 Platinum device in tandem with Peschke riboflavin solution for crosslinking?
"The PXL-330 Platinum device, combined with Peschke riboflavin solution for crosslinking, was first researched in 2002 at the National Cancer Centre of Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC). To date, 121 trials have been completed while there are currently 177 clinical studies recruiting participants; many located in Brecksville, Ohio."
What medical conditions tend to be treated with the PXL-330 Platinum device coupled with Peschke riboflavin solution?
"PXL-330 Platinum device combined with Peschke riboflavin solution is most commonly prescribed as nutritional therapy. It can also be taken to alleviate a range of conditions including vitamin deficiency, joint discomfort and supplementing vitamins."
Are there any slots currently open for enrollment in this research endeavor?
"Affirmative. Clinicaltrials.gov documents confirm that this investigation was launched on June 1st 2020 and is accepting applicants at present. The trial site requires 300 volunteers from 2 locations to take part in the study."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger